MedPath

浙江施强制药有限公司

Ownership
-
Established
2010-08-18
Employees
-
Market Cap
-
Website
http://www.cnstrong.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Tofacitinib Citrate Tablets

Product Name
枸橼酸托法替布片
Approval Number
国药准字H20254279
Approval Date
May 27, 2025
NMPA

Vardenafil hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20249029
Approval Date
Oct 9, 2024
NMPA

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20244668
Approval Date
Aug 20, 2024
NMPA

复方玄驹胶囊

Approval Number
国药准字Z20060462
Approval Date
Sep 16, 2021
NMPA

Potassium Sodium Hydrogen Citrate Granules

Product Name
枸橼酸氢钾钠颗粒
Approval Number
国药准字H20203639
Approval Date
Dec 2, 2020
NMPA

山海丹颗粒

Approval Number
国药准字Z20153023
Approval Date
Mar 20, 2020
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath